Roberta Ballard: Clinical Trials

2 trials sponsored by Roberta Ballard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Roberta Ballard: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
Infasurf surfactant (ONY, Inc.), Sham (No Treatment) - Bronchopulmonary Dysplasia
Phase 3CompletedRoberta Ballard5112010-01-012021-05-13
Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
Infasurf (ONY Inc.), Sham - Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction), Bronchopulmonary Dysplasia
Phase 3CompletedRoberta Ballard852008-01-012021-05-11

Conditions studied

Bronchopulmonary Dysplasia (2)  ·  Premature Birth (2)  ·  Surfactant Dysfunction (2)  ·  Respiratory Distress Syndrome (1)

Interventions

salicylhydroxamic acid (2)  ·  Air (1)  ·  Therapeutics (1)  ·  calfactant (1)

Countries

United States (2)

Top investigators

Roberta A Ballard, MD (2)

Results publications

PMID 26500107, PMID 27583380, PMID 28100402, PMID 29627188

NIH funding

U01HL094338 (1)